Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8758 |
High Similarity |
NPD4584 |
Approved |
0.8733 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD2420 |
Approved |
0.8333 |
Intermediate Similarity |
NPD2421 |
Approved |
0.8303 |
Intermediate Similarity |
NPD3051 |
Approved |
0.8269 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.8187 |
Intermediate Similarity |
NPD4017 |
Approved |
0.8144 |
Intermediate Similarity |
NPD2969 |
Approved |
0.8144 |
Intermediate Similarity |
NPD2970 |
Approved |
0.8095 |
Intermediate Similarity |
NPD27 |
Approved |
0.8095 |
Intermediate Similarity |
NPD2489 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD7298 |
Approved |
0.8026 |
Intermediate Similarity |
NPD3109 |
Approved |
0.8026 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD3639 |
Approved |
0.795 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.795 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7935 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7895 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7892 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7882 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7849 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7844 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7844 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6030 |
Approved |
0.784 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.784 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7829 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7829 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7829 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD5754 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.7753 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7727 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7727 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7665 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7613 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7613 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7609 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7598 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7593 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7593 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7400 |
Phase 3 |
0.7584 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7569 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7569 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7558 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2560 |
Approved |
0.75 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD2492 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7444 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7435 |
Intermediate Similarity |
NPD4859 |
Phase 1 |
0.743 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.743 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7425 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7412 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7412 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7411 |
Intermediate Similarity |
NPD3763 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7366 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7366 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7353 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7353 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7341 |
Intermediate Similarity |
NPD6037 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7268 |
Intermediate Similarity |
NPD3349 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5156 |
Approved |
0.725 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7247 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7247 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7225 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7216 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7211 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7202 |
Intermediate Similarity |
NPD1914 |
Approved |
0.7198 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7198 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2606 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2605 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3594 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3816 |
Phase 1 |
0.7194 |
Intermediate Similarity |
NPD3815 |
Phase 1 |
0.7193 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7247 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD4107 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7135 |
Intermediate Similarity |
NPD3408 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD3635 |
Approved |
0.7111 |
Intermediate Similarity |
NPD3885 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7098 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7098 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7072 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD5457 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD6747 |
Phase 1 |
0.7048 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD4482 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7017 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD2358 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7294 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.6995 |
Remote Similarity |
NPD3057 |
Approved |
0.6994 |
Remote Similarity |
NPD5720 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7119 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD4237 |
Approved |
0.6982 |
Remote Similarity |
NPD7020 |
Approved |
0.6982 |
Remote Similarity |
NPD7019 |
Approved |
0.698 |
Remote Similarity |
NPD8318 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD4725 |
Approved |
0.697 |
Remote Similarity |
NPD4721 |
Approved |
0.697 |
Remote Similarity |
NPD4726 |
Approved |
0.6962 |
Remote Similarity |
NPD7905 |
Discontinued |
0.6957 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6947 |
Remote Similarity |
NPD5582 |
Discontinued |
0.6935 |
Remote Similarity |
NPD7827 |
Phase 1 |
0.6931 |
Remote Similarity |
NPD7262 |
Phase 1 |
0.6928 |
Remote Similarity |
NPD4257 |
Approved |
0.6928 |
Remote Similarity |
NPD4256 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD6618 |
Phase 2 |
0.6915 |
Remote Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD7047 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.6911 |
Remote Similarity |
NPD5564 |
Approved |
0.6911
|
Remote Similarity |
NPD7034 |
Discontinued |